Casali, P. G.Abecassis, N.Bauer, S.Biagini, R.Bielack, S.Bonvalot, S.Boukovinas, I.Bovee, J. V. M. G.Brodowicz, T.Broto, J. M.Buonadonna, A.De Alava, E.Dei Tos, A. P.Del Muro, X. G.Dileo, P.Eriksson, M.Fedenko, A.Ferraresi, V.Ferrari, A.Ferrari, S.Frezza, A. M.Gasperoni, S.Gelderblom, H.Gil, T.Grignani, G.Gronchi, A.Haas, R. L.Hannu, A.Hassan, B.Hohenberger, P.Issels, R.Joensuu, H.Jones, R. L.Judson, I.Jutte, P.Kaal, S.Kasper, B.Kopeckova, K.Krakorova, D. A.Le Cesne, A.Lugowska, I.Merimsky, O.Montemurro, M.Pantaleo, M. A.Piana, R.Picci, P.Piperno-Neumann, S.Pousa, A. L.Reichardt, P.Robinson, M. H.Rutkowski, P.Safwat, A. A.Schoffski, P.Sleijfer, S.Stacchiotti, S.Hall, K. SundbyUnk, M.Van Coevorden, F.Van der Graaf, W.Whelan, J.Wardelmann, E.Zaikova, O.Blay, J. Y.ESMO Guidelines Comm EURACAN2023-02-122023-02-122018-10-010923-7534http://hdl.handle.net/10668/18935enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Phase-ii trialNeoadjuvant/adjuvant imatinib mesylateAdjuvant imatinibCarney-stratakisDose imatinibGistMutationsSurgeryProgressionRecurrenceresearch articleopen access10.1093/annonc/mdy0951569-8041http://www.annalsofoncology.org/article/S0923753419316916/pdf448047900006